Skip To Main

Why are people turning to compounded GLP-1 medications right now?

Recent shortages and high demand for brand-name GLP-1 medications like Ozempic®, Wegovy®, Mounjaro®, and Zepbound® have made it harder for some patients to access treatment. As a result, compounding pharmacies have started offering versions of semaglutide and tirzepatide—but these alternatives aren’t identical to FDA-approved products and may carry safety risks.

Cookie Usage

Our Website uses cookies to provide you with the best experience. Please select your preferences below. Learn more in our Privacy Policy.

  • NecessaryAlways active

    Required for the site to function, including storing your cookie preferences.

  • Marketing & Analytics

    Help us understand how you use our site and measure marketing performance. Includes Google Tag Manager, HubSpot, Microsoft Clarity, VWO, and Digioh.

  • Advertising

    Used by our advertising and affiliate partners, including Commission Junction.